China approves 19 innovative drugs for commercial health insurance, opening new market opportunities for global and local ...

The new generation of appetite-suppressing drugs such as Mounjaro may prove to be the most rapidly adopted genre of pharmaceuticals ever launched into the market. In the space of two years, they have ...

After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...

Regulators have the authority to penalize false advertising. What they cannot do is enact rules so heavy that legitimate ads cannot run.

The drug regulator’s expert panel has also recommended bringing all antimicrobials under the “new drug” definition in the New ...

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

Indian drugmaker Dr Reddy's signed an exclusive licensing pact with Australia's Immutep to develop and distribute the ...

While many headline-grabbing biologics and advanced therapeutics like cell and gene therapies are approved as injectables, ...

Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

GS Equity Income Fund underperformed in Q3. Discover key contributors like Oracle & J&J, and detractors Kenvue & Honeywell.

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL ...